143 related articles for article (PubMed ID: 3980990)
1. Therapeutic potential of rat monoclonal antibodies: isotype specificity of antibody-dependent cell-mediated cytotoxicity with human lymphocytes.
Hale G; Clark M; Waldmann H
J Immunol; 1985 May; 134(5):3056-61. PubMed ID: 3980990
[TBL] [Abstract][Full Text] [Related]
2. K-cell-mediated cytotoxicity induced with rat monoclonal antibodies. I. Antibodies of various isotypes differ in their ability to induce cytotoxicity mediated by rat and human effectors.
Chassoux DM; Linares-Cruz LG; Bazin H; Stanislawski M
Immunology; 1988 Dec; 65(4):623-8. PubMed ID: 3220507
[TBL] [Abstract][Full Text] [Related]
3. Importance of antibody isotype in monoclonal anti-idiotype therapy of a murine B cell lymphoma. A study of hybridoma class switch variants.
Kaminski MS; Kitamura K; Maloney DG; Campbell MJ; Levy R
J Immunol; 1986 Feb; 136(3):1123-30. PubMed ID: 3484499
[TBL] [Abstract][Full Text] [Related]
4. Importance of immunoglobulin isotype in human antibody-dependent, cell-mediated cytotoxicity directed by murine monoclonal antibodies.
Kipps TJ; Parham P; Punt J; Herzenberg LA
J Exp Med; 1985 Jan; 161(1):1-17. PubMed ID: 3918141
[TBL] [Abstract][Full Text] [Related]
5. Cross-reaction of a rat-anti-mouse phagocyte-specific monoclonal antibody (anti-Mac-1) with human monocytes and natural killer cells.
Ault KA; Springer TA
J Immunol; 1981 Jan; 126(1):359-64. PubMed ID: 7451976
[TBL] [Abstract][Full Text] [Related]
6. Influence of antibody isotype on passive serotherapy of lymphoma.
Denkers EY; Badger CC; Ledbetter JA; Bernstein ID
J Immunol; 1985 Sep; 135(3):2183-6. PubMed ID: 2862210
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies which react with lymphocyte-lysed target cells and which cross-react with complement-lysed ghosts.
Ward RH; Lachmann PJ
Immunology; 1985 Sep; 56(1):179-88. PubMed ID: 4043993
[TBL] [Abstract][Full Text] [Related]
8. Unusually efficient tumor cell lysis by human effectors of antibody-dependent cellular cytotoxicity mediated by monoclonal antibodies.
Christiaansen JE; Sears DW
Cancer Res; 1984 Sep; 44(9):3712-8. PubMed ID: 6744288
[TBL] [Abstract][Full Text] [Related]
9. Reconstitution of natural cell-mediated cytotoxicity with specific antibodies.
Takasugi J; Koide Y; Takasugi M
Eur J Immunol; 1977 Dec; 7(12):887-92. PubMed ID: 75804
[TBL] [Abstract][Full Text] [Related]
10. Antibody-mediated killing of human tumor cells by attached effector cells.
Hellström I; Garrigues U; Lavie E; Hellström KE
Cancer Res; 1988 Feb; 48(3):624-7. PubMed ID: 3335025
[TBL] [Abstract][Full Text] [Related]
11. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
Phillips KE; Herring B; Wilson LA; Rickford MS; Zhang M; Goldman CK; Tso JY; Waldmann TA
Cancer Res; 2000 Dec; 60(24):6977-84. PubMed ID: 11156399
[TBL] [Abstract][Full Text] [Related]
12. Carbohydrate chains on IgG2b: a requirement for efficient feedback immunosuppression.
Heyman B; Nose M; Weigle WO
J Immunol; 1985 Jun; 134(6):4018-23. PubMed ID: 3872908
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous occurrence of immunoglobulin-dependent and immunoglobulin-independent mechanisms in natural cytotoxicity of human lymphocytes.
Pape GR; Troye M; Axelsson B; Perlmann P
J Immunol; 1979 Jun; 122(6):2251-60. PubMed ID: 448127
[No Abstract] [Full Text] [Related]
14. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.
Bishop GA; Marlin SD; Schwartz SA; Glorioso JC
J Immunol; 1984 Oct; 133(4):2206-14. PubMed ID: 6206157
[TBL] [Abstract][Full Text] [Related]
15. Immunosuppression with monoclonal antibodies. A model to determine the rules for effective serotherapy.
Cobbold SP; Thierfelder S; Waldmann H
Mol Biol Med; 1983 Oct; 1(3):285-304. PubMed ID: 6209527
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibodies against T cell differentiation antigens initiate stimulation of monocyte/macrophage oxidative metabolism.
Descamps-Latscha B; Golub RM; Nguyen AT; Feuillet-Fieux MN
J Immunol; 1983 Nov; 131(5):2500-7. PubMed ID: 6195264
[TBL] [Abstract][Full Text] [Related]
17. Immunoregulation by monoclonal sheep erythrocyte-specific IgG antibodies: suppression is correlated to level of antigen binding and not to isotype.
Heyman B; Wigzell H
J Immunol; 1984 Mar; 132(3):1136-43. PubMed ID: 6363534
[TBL] [Abstract][Full Text] [Related]
18. Reactivities of mouse monoclonal antibody K2.7 to renal cancers in complement dependent cytotoxicity and antibody dependent cell-mediated cytotoxicity.
Kinouchi T; Bander NH; Kotake T
J Urol; 1995 Jul; 154(1):288-92. PubMed ID: 7776448
[TBL] [Abstract][Full Text] [Related]
19. Human K cell mediated cytotoxicity.
Ziegler HK; Henney CS
Ric Clin Lab; 1978; 8(1-2):1-16. PubMed ID: 212817
[No Abstract] [Full Text] [Related]
20. A mechanistic perspective of monoclonal antibodies in cancer therapy beyond target-related effects.
Strome SE; Sausville EA; Mann D
Oncologist; 2007 Sep; 12(9):1084-95. PubMed ID: 17914078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
